Statistics on Biotechnology Use  
Results by sector of operation
Company sector.  Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production
Unidades: specified in variables

,Total,Main,Secondary dwellings,Tool,
Companies that carry out R&D in Biotechnology,1.133,603,173,357,
%Companies according to biotechnology used: Genetic code,33,39,28,25,
%Companies according to biotechnology used: Functional units,41,44,39,36,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,24,29,19,17,
%Companies according to biotechnology used: Bioprocesses,50,45,42,61,
%Companies according to biotechnology used: Sub-cellular organisms,6,8,5,3,
%Companies according to biotechnology used: Bio-computing,24,33,19,12,
%Companies according to biotechnology used: Nanobiotechnology,13,17,15,6,
%Companies according to biotechnology used: Other,14,16,16,11,
%Company by field(s) of ultimate application of biotechnology use: Human Health,45,59,41,24,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,18,21,14,13,
%Company by field(s) of ultimate application of biotechnology use: Food products,31,25,28,43,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,22,19,27,26,
%Company by field(s) of ultimate application of biotechnology use: Environment,14,11,22,13,
%Company by field(s) of ultimate application of biotechnology use: Industry,12,13,16,8,
Personnel in R&D in biotechnology (no. of persons),11.510,6.862,1.521,3.127,
Personnel in R&D in biotechnology (no. of persons): Researchers,6.202,3.759,900,1.543,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,5.308,3.103,621,1.584,
Personnel in R&D in biotechnology (no. of persons): women,6.389,4.015,750,1.624,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,3.304,2.079,442,783,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,3.086,1.937,308,841,
Personnel in R&D in biotechnology (FTE),8.236,9,5.430,2,989,7,1.817,
Personnel in R&D in biotechnology (FTE): Researchers,4.596,1,3.001,4,642,6,952,1,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,3.640,8,2.428,8,347,1,864,9,
Personnel in R&D in biotechnology (FTE): women,4.698,5,3.180,1,503,1,1.015,3,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.512,5,1.684,7,323,4,504,4,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,2.186,1.495,4,179,7,510,9,
Internal expenditure on R&D (thousands of euros),769.431,541.881,63.951,163.599,
1) By nature of the expense: Current expenses,719.715,502.430,60.603,156.683,
1.1) Remuneration to researchers,221.447,151.282,26.154,44.011,
1.2) Remuneration to technicians and assistants,122.809,83.753,10.469,28.587,
1.3) Other current expenses,375.459,267.396,23.979,84.084,
2) By nature of the expense: Capital expenses,49.715,39.451,3.348,6.916,
2.1) Land and buildings,9.521,7.987,676,858,
2.2) Equipment and instruments,30.466,22.742,2.475,5.248,
2.3) Acquisition of specific R+D software,1.810,1.212,89,509,
2.4) Otros productos de propiedad intelectual específicos para I+D,7.919,7.510,108,301,
1.1) By origin of the funds: Own funds,490.913,347.382,40.321,103.210,
1.2) By origin of the funds: From companies,82.548,62.516,5.356,14.676,
1.3) By origin of the funds: Public Administration funds,96.809,67.645,12.905,16.259,
1.4) By origin of the funds: From Universities,197,193,0,4,
1.5) By origin of the funds: From non profit private institutions,4.766,1.422,0,3.344,
1.6) By origin of the funds: Foreign funds,94.197,62.723,5.369,26.106,
Purchase of R&D services in biotechnology (thousands of euros),120.281,102.804,9.714,7.763,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,69.564,57.335,8.455,3.773,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,50.718,45.469,1.259,3.990,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,45,52,42,35,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,9,17,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,16,14,20,18,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,14,14,16,12,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets,16,16,20,14,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels,18,20,18,16,
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception,15,15,18,15,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,39,38,32,
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost,52,54,56,46,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,20,20,21,20,
% Companies that have requested biotechnology patents,15,21,11,7,
Number of patents requested,681,485,100,96,
% Companies with income of an international origin related to biotechnological activities,24,3,34,1,12,6,13,5,
% Turnover representing income of an international origin related to biotechnological activities,1,9,0,1,
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU,59,6,60,2,79,3,54,7,
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries,40,4,39,8,20,7,45,4,
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services,80,4,78,5,17,9,96,8,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,16,5,19,3,0,6,1,4,
% Income of an international origin related with activities according to the classification: Operating source abroad,2,2,1,3,70,4,1,8,
% Income of an international origin related with activities according to the classification: Other,0,9,0,9,11,1,0,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute